Organon & Co
XMUN:7XP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Organon & Co
XMUN:7XP
|
US |
|
E
|
Essex Property Trust Inc
F:EXP
|
US |
|
Sekisui Chemical Co Ltd
F:SUI
|
JP |
|
Avolta AG
SIX:AVOL
|
CH |
|
S
|
Six Flags Entertainment Corp
F:6FE
|
US |
|
Ozon Holdings PLC
MOEX:OZON
|
CY |
|
S&T Bancorp Inc
NASDAQ:STBA
|
US |
|
Mind Medicine (MindMed) Inc
F:MMQ
|
US |
|
Metcash Ltd
ASX:MTS
|
AU |
|
P
|
Public Power Corporation SA
ATHEX:PPC
|
GR |
|
Extreme Networks Inc
NASDAQ:EXTR
|
US |
|
L
|
Lennar Corp
XBER:LNN
|
US |
|
Z
|
Zimmer Biomet Holdings Inc
F:ZIM
|
US |
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
Infineon Technologies AG
F:IFXA
|
DE |
|
N
|
Naturgy Energy Group SA
DUS:GAN
|
ES |
|
Wipro Ltd
NYSE:WIT
|
IN |
|
S
|
Smith & Nephew PLC
DUS:NPW1
|
UK |
|
S
|
Sirius XM Holdings Inc
LSE:0L6Z
|
US |
|
N
|
Norfolk Southern Corp
DUS:NFS
|
US |
Bankruptcy Probability
Organon & Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Organon & Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Organon & Co
NYSE:OGN
|
3.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
567.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
232.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
284.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
204.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
334.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Organon & Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Organon & Co has total debt of 8.6B USD. This includes both short-term (0 USD) and long-term (8.6B USD) debt.
You can find a full breakdown on its Balance Sheet.
